Massive study decodes breast Cancer's molecular secrets

NCT ID NCT01840293

First seen Jan 07, 2026 · Last updated Jun 11, 2026 · Updated 28 times

Summary

This study aims to understand breast cancer better by analyzing proteins and genes in tumor samples from 1,780 people with primary or recurrent/metastatic breast cancer. Researchers will look at specific markers like S100 protein and hormone receptors to learn how cancer progresses and responds to treatment. The goal is to find new clues that could improve future treatments, not to test a new therapy directly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Beaumont Hospital

    RECRUITING

    Dublin, Ireland

    Contact

    Contact

    Contact Phone: •••-•••-••••

  • Cork University Hospital

    RECRUITING

    Cork, Ireland

    Contact Phone: •••-•••-••••

    Contact

  • St James's Hospital

    COMPLETED

    Dublin, Ireland

  • St. Vincent's University Hospital

    RECRUITING

    Dublin, Ireland

    Contact Phone: •••-•••-••••

    Contact

  • University Hospital Limerick

    ACTIVE_NOT_RECRUITING

    Limerick, Ireland

  • University Hospital Waterford

    RECRUITING

    Waterford, Ireland

    Contact Phone: •••-•••-••••

    Contact

Conditions

Explore the condition pages connected to this study.